sb 203580 has been researched along with withanolides in 2 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (withanolides) | Trials (withanolides) | Recent Studies (post-2010) (withanolides) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 789 | 1 | 647 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Askar, I; Chan, D; Flanagan, JG; Guo, X; Lam, S; Livne-Bar, I; Nahirnyj, A; Sivak, JM | 1 |
| Ewendt, F; Föller, M | 1 |
2 other study(ies) available for sb 203580 and withanolides
| Article | Year |
|---|---|
Pharmacologic inhibition of reactive gliosis blocks TNF-α-mediated neuronal apoptosis.
Topics: Animals; Apoptosis; Astrocytes; Corneal Injuries; Disease Models, Animal; Gliosis; Imidazoles; Intermediate Filaments; Male; Mice, Inbred C57BL; Neuroglia; p38 Mitogen-Activated Protein Kinases; Polymerization; Pyridines; Retinal Neurons; Tumor Necrosis Factor-alpha; Withanolides | 2016 |
p38MAPK controls fibroblast growth factor 23 (FGF23) synthesis in UMR106-osteoblast-like cells and in IDG-SW3 osteocytes.
Topics: Animals; Anisomycin; Cell Line; Enzyme Inhibitors; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Flavanones; Gene Expression Regulation; Imidazoles; Mice; NF-kappa B; Osteoblasts; Osteocytes; p38 Mitogen-Activated Protein Kinases; Pyridines; Rats; Signal Transduction; Withanolides | 2019 |